Skip to content
Passage Bio logo

Passage Bio Alternatives & Competitors

12 companies similar to Passage Bio — Our mission is to improve the lives of patients with neurodegenerative diseases

Companies similar to Passage Bio

Lexeo Therapeutics logo — alternative to Passage Bio

Lexeo Therapeutics

Advancing science with curative potential for both cardiovascular and APOE4 associated Alz...

VBL Therapeutics (Nasdaq:VBLT) logo — alternative to Passage Bio

VBL Therapeutics (Nasdaq:VBLT)

Engineering the future of targeted medicines, breaking barriers to develop the next genera...

ProJenX logo — alternative to Passage Bio

ProJenX

ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...

HuidaGene Therapeutics logo — alternative to Passage Bio

HuidaGene Therapeutics

辉大,给患者回答 | Answering the Patients!

Rival Readout

Competing with Passage Bio? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Spinogenix, Inc. logo — alternative to Passage Bio

Spinogenix, Inc.

Developing a new class of therapeutics for neurodegenerative and psychiatric diseases

GenSight Biologics logo — alternative to Passage Bio

GenSight Biologics

Applying pathbreaking science to transform the lives of patients with severe retinal neuro...

Cognition Therapeutics, Inc. logo — alternative to Passage Bio

Cognition Therapeutics, Inc.

Advancing Accessible Solutions for Complex Neurodegenerative Diseases

Vigil Neuroscience logo — alternative to Passage Bio

Vigil Neuroscience

Harnessing the power of microglia to transform treatments for neurodegenerative diseases

Alector logo — alternative to Passage Bio

Alector

We are on a mission to make brain disorders history.

AgeneBio logo — alternative to Passage Bio
Character Biosciences logo — alternative to Passage Bio

Character Biosciences

A patient-driven drug discovery platform for diseases of aging

ReviR Therapeutics logo — alternative to Passage Bio

ReviR Therapeutics

Improve human health by Revising drug discovery using RNA and AI technologies

About Passage Bio

Passage Bio, founded in 2017 and headquartered in the United States, is a clinical stage genetic medicines company dedicated to improving the lives of patients with neurodegenerative diseases. The company operates within the Biotechnology, Health Care, and Health and Wellness industries. Their mission, encapsulated by...

Services

Development of genetic medicines, Clinical trials for CNS disorders, Gene therapy solutions

Target Customers

Patients with neurodegenerative diseases, Healthcare professionals specializing in CNS disorders, Biotech and pharmaceutical investors

Business keywords

Neurodegenerative Diseases, Genetic Medicines, Clinical Stage, One-time Therapies, Lysosomal Function Restoration, Progranulin Elevation, AAV-delivered Therapeutics, Monogenic CNS Diseases, Gene Therapy, Frontotemporal Dementia, Research Collaboration, Preclinical Work, Clinical Development, Regulatory Affairs, Patient Advocacy Outreach

Business Model

B2B2C, B2B

Revenue Model

One Time Purchase, Value Based Pricing, Licensing

Frequently Asked Questions

Companies similar to Passage Bio include Lexeo Therapeutics, VBL Therapeutics (Nasdaq:VBLT), ProJenX, HuidaGene Therapeutics, Spinogenix, Inc.. They work in Biotechnology and Health Care and share Passage Bio's focus on neurodegenerative diseases, gene therapy and research collaboration.
Bounce Watch lists 12 companies that share Passage Bio's industries and are closest to it in business tags, services, target customers, business model and size.
Passage Bio, founded in 2017 and headquartered in the United States, is a clinical stage genetic medicines company dedicated to improving the lives of patients with neurodegenerative diseases. The company operates within the Biotechnology, Health Care, and Health and Wellness industries. Their mission, encapsulated by...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Passage Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Passage Bio on 30 Jun 2026. The 11 companies listed here were last checked between 12 Sep 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout